Healthcare Pharmaceutical Biotech

Viemed Healthcare Announces Third Quarter 2026 Financial Results

November 4, 2026 5:00 PM

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three and nine months ended September 30, 2026, and updated guidance for the full year ending December 31, 2026. Third Quarter 2026 Financial and Operational Highlights (all dollar amounts are USD): Net...

Read more

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity

November 4, 2026 4:15 PM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the three and nine months ended September 30, 2026. "Zomedica delivered record third quarter revenue, continued year-over-year growth across our business, and made further progress in managing and improving...

Read more

Payer Outsourcing Enters a Reset as AI Rewrites Health Plan Economics, Black Book finds

November 4, 2026 4:00 PM

U.S. health plans are entering 2027 with stronger industry profitability but a persistent administrative cost problem, accelerating a broad reassessment of outsourcing, artificial intelligence, automation and internal operating models, according to the newly released Black Book Payer, Health Plan & Managed Care Outsourcing Outlook 2027. Claims-adjustment and administrative expenses across the U.S. health insurance industry reached approximately...

Read more

Elevate Healthcare Introduces OpSpace, the Operations Mission Control for Healthcare Simulation

November 4, 2026 3:30 PM

Elevate Healthcare, a leader in healthcare simulation, today introduced OpSpace, an operations platform built to help academic and hospital simulation centers expand their capacity to educate tomorrow's healthcare professionals. By bringing planning, coordination and scheduling into one connected workspace, OpSpace helps budget-conscious centers do more with the people, spaces and equipment they already have-and gives educators more time to...

Read more

Action Behavior Centers BCBAs Partner With Treeline Pass to Support Autistic Adults in Denver During ABCaba Clinical Conference

November 4, 2026 2:00 PM

Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), hosted a Community Impact Event with Treeline Pass during its 2026 ABCaba Clinical Conference on October 16-17 in Denver, Colorado. ABC operates more than 450 ABA therapy centers across nine states, including more than 40 centers across the greater Denver area. ABC teammates give...

Read more

Why Trusted Pharmacists Remain One of Health Care’s Most Important Relationships

November 4, 2026 2:00 PM

Originally published on CVS Health Company Newsroom Key points Eighty-four percent of U.S. adults view pharmacies as credible health care sources, reinforcing pharmacists' role as a trusted source of health guidance. Pharmacists support health beyond prescriptions by answering medication questions, helping patients manage chronic conditions and providing recommended vaccinations. Trusted pharmacist relationships can help people better understand...

Read more

Midterm 2026 Healthcare Ballot Results and Impacts Across 13 States: Black Book Research Follow-Up

November 4, 2026 11:10 AM

State ballot decisions are preserving South Dakota's Medicaid expansion requirement, blocking California's proposed spending mandate for covered nonprofit community health centers, and establishing different paths for reproductive care, healthcare investment and public financing across the country, according to Black Book Market Research's update to its pre-election study, "Healthcare on the Mid-Term Ballot 2026." The update follows Black Book's...

Read more

Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study

November 4, 2026 11:05 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1469, the Company's investigational mRNA vaccine candidate against Bundibugyo ebolavirus (BDBV), has been recommended to advance into a Phase 2/3 efficacy study in the Democratic Republic of the Congo (DRC), supported by encouraging preclinical and Phase 1 clinical data. The recommendation follows an October 22 review of available evidence by the World Health Organization's Technical Advisory...

Read more

Merck KGaA, Darmstadt, Germany Hosts Change Chemistry European Forum To Advance Safety and Sustainability in Chemistry

November 4, 2026 11:00 AM

Merck KGaA, Darmstadt, Germany, recently hosted Change Chemistry at its global headquarters for the nonprofit organization's 2026 European Forum. Bringing together leaders from across the chemical value chain, the two-day event focused on "Building the Infrastructure for Safe and Sustainable Chemistry." Through interactive discussions and working sessions, participants explored how companies, policymakers and innovators can strengthen the market...

Read more

Rejuvené MD Expands Physician-Led Skin Rejuvenation with Tixel-2

November 4, 2026 10:45 AM

Rejuvené MD, an El Paso clinic integrating dermatology, aesthetic and laser medicine, restorative wellness, and longevity medicine, today announced the addition of Tixel-2 to its skin rejuvenation services. The new technology expands the clinic's physician-led treatment options for concerns involving skin texture, tone, fine lines, and laxity, including the delicate peri-orbital and peri-oral areas. Rejuvené MD is owned and led by Dr. Karen...

Read more

Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting

November 4, 2026 9:50 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that initial clinical data from its ongoing Phase 1/2 study of mRNA-2808 have been selected for oral presentation at the 68th American Society of Hematology (ASH) Annual Meeting, taking place December 12-15, 2026, in New Orleans, Louisiana. mRNA-2808 is an investigational multiplexed mRNA therapeutic designed to enable in vivo production of three distinct T-cell engagers targeting BCMA, GPRC5D and...

Read more

Cosmos Health's Amazon UK Business Surpasses $2 Million in TTM Sales, Up 90%, with a 23% Net Profit Margin; Expects Sales to Grow Approximately 72% to $3.9 Million Over the Next Twelve Months

November 4, 2026 9:27 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an update on its Amazon UK business, reporting strong sales growth and profitability for the trailing twelve months ("TTM") from November 1, 2025 to November 2, 2026. Amazon UK Performance Over the trailing twelve months, Amazon UK sales reached £1.71 million, or approximately $2.27 million,...

Read more

SynAct Pharma Announces Attendance and Presentation at Upcoming Investor Conferences

November 4, 2026 9:20 AM

SynAct Pharma (STO:SYNACT) - SynAct Pharma AB (publ) ("SynAct") (Nasdaq Stockholm:SYNACT), a clinical-stage biotechnology company focused on treating inflammation through a novel therapeutic approach known as "pro-resolution", today announces its attendance at upcoming investor conferences through the fourth quarter of 2026. BIO-Europe, November 9-11, Cologne, Germany Chief Business Officer Mads Bjerregaard attending. BIO-Europe brings together...

Read more

Cantargia Presents Promising Early Results with Nadunolimab in MDS and AML Ahead of ASH 2026

November 4, 2026 9:15 AM

Cantargia AB (publ) (Nasdaq Stockholm:CANTA), a clinical-stage biotechnology company focused on antibody-based therapeutics targeting IL1RAP, today announced that an abstract with early results from the Phase 1b/2a trial of nadunolimab in higher-risk myelodysplastic syndromes (MDS) and adverse risk relapsed or refractory (R/R) acute myeloid leukemia (AML) has been published ahead of the American Society of Hematology (ASH) Annual Meeting. The...

Read more

How Are Your Wound Centers Doing Today? Wound Care Advantage's New AI Huddle Answers Before Clinic Opens

November 4, 2026 9:00 AM

Hospitals have been sold plenty of AI pilots, and few of them have shipped. MIT researchers found that 95% of enterprise generative AI pilots produced no measurable financial return.1 The work those pilots promised to fix is still waiting. In a hospital wound center, the first hours of every day go to pulling schedules, confirming patients, checking treatment clearances and chasing hyperbaric authorizations. A health system executive who wants...

Read more

MediQuant Expands DataArk to Help Healthcare CIOs Close the Data Retention Gap Between Policies and Practice

November 4, 2026 9:00 AM

MediQuant, a leader in healthcare data archiving and data lifecycle management, is introducing the next generation of its DataArk® platform, expanding traditional archiving capabilities to help health systems better manage the cost, risk and complexity of data throughout its lifecycle. The enhanced platform gives healthcare organizations greater visibility into what legacy data they retain, how old it is, how it is used and what it costs to...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Moves $250,000 Software Agreement Into Active Development

November 4, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today provided an execution update on the software agreement announced October 14, valued at up to $250,000, with a client group that includes current and retired professional athletes. The first payment under the agreement has been initiated, and technical work is now underway. The engagement covers software development that includes a web-based interface integrated with a custom enterprise software...

Read more

An Honest Take on Motherhood and Mental Health

November 4, 2026 8:45 AM

We talk a lot about what it takes to have a healthy pregnancy and a healthy baby. We talk much less about what it takes for a mother to be healthy, especially when it comes to her mental health. That gap matters. Maternal mental health conditions are common and treatable, yet too many women still struggle without receiving the recognition, support or care they need. Motherhood does not make someone immune to serious mental health challenges. Yet...

Read more

TriageLogic's MedMessage Automate Frees Up Over 37 Hours of Staff Time in the First Three Business Days

November 4, 2026 8:00 AM

TriageLogic, a provider of nurse triage software for physician groups, today announced early results from a multi-location physician group using MedMessage Automate™. The practice processed 749 patient messages through the nurse triage software in its first three business days. That represents an estimated 37 hours of staff capacity freed back to patient care. The physician group includes 25 physicians across 10 locations. Of the 749 tickets...

Read more

CK Life Sciences' Sequencio Therapeutics to Present New Data from Lead Cancer Vaccine Programmes at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting

November 3, 2026 10:51 PM

Sequencio Therapeutics Company Limited ("Sequencio"), a subsidiary of CK Life Sciences Int'l., (Holdings) Inc. ("CK Life Sciences"), today announced that the Society for Immunotherapy of Cancer (SITC) has selected two abstracts from Sequencio for presentation at its 41st Annual Meeting, taking place 4-8 November 2026 in Phoenix, Arizona, USA. The studies evaluated key elements of Sequencio's Prime-Infiltrate-Ignite-Translate (PINT) translational...

Read more